More importantly, double staining for iron with Perl’s blue and for CD45, an immune cell marker, revealed that LncRIM-mediated changes in iron levels were mostly located in breast cancer cells, not in other cells (Fig. 6a). Here, PTPRC is linked to breast carcinoma.